PA496M
PA496M has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 26, 2023: “Blocking AMPKαS496 phosphorylation improves mitochondrial dynamics and hyperglycemia in aging and obesity”.
1 paper studies it1 findingUpdated
- 1 lab in 1 country
- Funders: Johns Hopkins University and 3 more
- Animals1
What did studies of PA496M find?
1Studies of PA496M measured 1 outcome; the most studied are glucose production (1 study).
Glucose production
downin mice1
1 study
Glucose production
downin mice1
PA496M decreases glucose production in mice.
“Furthermore, these AMPK targeting peptides robustly suppress liver glucose production in obese mice.”
Animalsin obese miceliver
Cell chemical biology
Latest
Cell Chemical Biology
Blocking AMPKαS496 phosphorylation improves mitochondrial dynamics and hyperglycemia in aging and obesity
Experiments in miceHyperglycemia